Dan Frendl

Urologist @MayoUrology in AZ 🌵 🇺🇸 | All opinions are my own and not endorsed by @MayoClinic

[Matt Cooperberg @dr_coops]

Super reasonable recs re PSMA PET use from @JackAndrewsMD #wsaua25

[Dan Frendl @dfrendl]

Great conversation with @RepDavid and @JasonJamesonMD about AI in healthcare, improving efficiency and reducing administrative burden/waste. Thank you @AmerUrological for a fantastic Advocacy Summit #AUASummit25

[Arvin K. George, MD @arvinkgeorge]

#VAPOR2 investigators meeting to kickoff #FOCAL2024+

Looking forward to a great meeting tomorrow!

@FrancisMedical @dfrendl @AbhinavSidana @AliKasraeian @FryeUroOnc

D

[Derek Lomas @DerekLomas]

POSTER 2) Among men undergoing MR fusion prostate biopsy for unilateral PIRADS 3 or
4 lesions, transperineal biopsy resulted in greater disease detection for both targeted fusion and systematic samples. TP biopsy may provide a more thorough pre-treatment assessment for FT.

[Derek Lomas @DerekLomas]

@MayoUrology with two posters at #FOCAL2024 POSTER 1) Those are active surveillance with PIRADS 5 lesions disease have lower rates of high-grade disease on targeted biopsy, compared to those with no previous prostate cancer diagnosis. @dfrendl

[Dan Frendl @dfrendl]

@kvnkoo @jacob_thatcher @JeffNJurology Congratulations!

[Dan Frendl @dfrendl]

@LondonProstate1 And we of course know and practice surgery and radiation as the cornerstone of treating clinically significant prostate cancer. The course was very fair and balanced and emphasized avoiding over diagnosis and over treatment.

[Dan Frendl @dfrendl]

@LondonProstate1 Irony is that radiation is the most common modality used to over treat prostate cancer… For those interested in criticizing these courses they should join us to listen to what we discuss and help advance the science rather than make political commentary

[Dan Frendl @dfrendl]

Outstanding Expert Panel moderated by @LondonProstate1 discussing nuances of focal therapy energy and patient selection at #ipmasterclass24. @DerekLomas discussing our @MayoUrology experience

[Dan Frendl @dfrendl]

@FrancisMedical @MayoClinic @LanceMynderse We are excited to offer our patients with Gleason 3+4 prostate cancer and MRI visible localized prostate cancer the option to participate in the VAPOR2 clinical trial for focal therapy!

[Francis Medical @FrancisMedical]

🩺Last week, two Mayo sites performed their first #VAPOR2 cases: Thanks Dr @dfrendl of @MayoClinic AZ & Dr @LanceMynderse of @MayoClinic MN for testing #WaterVaporTherapy on #ProstateCancer using #Vanquish.

➡️ https://t.co/herXSlp9hw
#RandyBeahrs #MichaelHoey #ChrisDixon #ED #UI

[Hashim U. Ahmed @LondonProstate1]

Another win for focal therapy

Prostate cancer focal therapy (using HIFU & cryotherapy) is cost effective compared to radical therapy

Lower cost, better quality of life https://t.co/TR7CQuCUeh

[Zeyad Schwen MD @ZSchwen]

Day 2 VP @SBoorjian @CleClinicUro

@gwerneburg presenting his outstanding work on TP vs TR prostate biopsy microbiome

Mechanism for reduced post-biopsy sepsis!
@samhaywoodmd @cjweight @MayoUrology

[Dan Frendl @dfrendl]

Proud of my wife Anna Ward and the outstanding group of women leaders @MGHanesthesia for their work supporting our colleagues who are amazing mothers!

Championing the Mom: The Role of a Mother’s Support Group... : Anesthesia & Analgesia https://t.co/3XWMlyDtLJ

[Ram Pathak, M.D. @RamPathakMD]

@dfrendl and @DerekLomas and I at the @FocalSociety meeting. Looking forward for the collaborations coming soon. @MayoUrology

[Dr Andre Abreu @ALDCAbreu]

🎯 The TOP-Bx Global Delphi Consensus is in progress.

👩🏿‍⚕️👨🏼‍⚕️ Its aim: Address knowledge gaps for Transperineal Prostate Biopsy (T🎯P-Bx) Best Practices.

🧑🏾‍💻👩‍💻 Invited stakeholders, kindly complete the survey.

Thank you.

Like 👍🏾🩷, Share🫱🏾‍🫲🏽, Re-post 🔃

@USC_Urology #UroSoMe

[Dan Frendl @dfrendl]

Early vs Delayed Transurethral Surgery in Acute Urinary Retention: Does Timing Make a Difference? | Journal of Urology https://t.co/e2slU4eHAO

Excited JU is highlighting the association between early BPH surgery after acute retention and improved long-term outcomes

[Dan Frendl @dfrendl]

@AbhinavSidana @arvinkgeorge @FocalOneHIFU @AmirLebastchi They indicated no significant increase in morbidity with double tap in the small series. Subjectively this has been my experience as well, with exception of slightly more mild hematuria and slightly more sloughing

[Derek Lomas @DerekLomas]

It was great having our new @MayoUrology AZ colleague @dfrendl join us for the past few weeks in Rochester in our prostate cancer ablation and transperineal biopsy practice. Looking forward to continued collaboration! Thanks @MayoMitch for sending him up!

[Dan Frendl @dfrendl]

@DerekLomas @MayoUrology @MayoMitch Thank you to @DerekLomas, Dr. Mynderse and to the whole Mayo Rochester Urology department for being wonderful hosts and sharing your wealth of experience! Excited to collaborate from Mayo Arizona and thank you to @MayoMitch for your mentorship